Magnofit
291 mg + 98 mg + 10 mg
Aluminium Hydroxide Dried Gel + Magnesium Hydroxide + Oxethazaine
Segment 08 · Anti-ulcerants & Antacids
Magnofit291 mg + 98 mg + 10 mg
Aluminium Hydroxide Dried Gel + Magnesium Hydroxide + Oxethazaine
Also marketed as Tri Gel in selected markets
Magnofit
291 mg + 98 mg + 10 mg
Aluminium Hydroxide Dried Gel + Magnesium Hydroxide + Oxethazaine
Antacid with a local anaesthetic for heartburn and gastritis.
Export fast-track. DRAP export registration in about a month for products developed against export orders. Describe the formulation
- Generic composition
- Aluminium Hydroxide Dried Gel + Magnesium Hydroxide + Oxethazaine
- Strength
- 291 mg + 98 mg + 10 mg
- Dosage form
- Oral Suspension
- Pack sizes
- 120 ml
- Manufacturer
- Paramount Pharmaceuticals, Islamabad
- Licence
- DML 000439 · DRAP GMP
- Release
- Batch-tested, with Certificate of Analysis
For healthcare professionals. Registration status, brand names and pack presentations vary by market. Experienced a side effect? Report it here.
Magnofit
How it's made
Syrups, suspensions and drops are made by dissolving or dispersing the ingredients in purified water. Made in the general production section.
How all our dosage forms are made →- 01
Dispensing
Each raw material is released by QC, then weighed for the batch under a second person's check.
- 02
Preparation
Ingredients are dissolved or dispersed in purified water in a jacketed mixing vessel.
- 03
Mixing and filtration
Solutions are filtered; suspensions are homogenised so the dose is the same in every spoonful.
- 04
Filling
Bottles are filled to a set volume and sealed.
- 05
Labelling
Each bottle is labelled with the batch number and expiry date.
Batch release tests
- Fill volume
- Assay of the active ingredient
- pH
- Viscosity or specific gravity
- Microbial limits
Limits for this product are on each batch's Certificate of Analysis.